DEPLOYDatabase

Deployment

BrainQ Non-Invasive BCI at Washington, DC, USA

AI-powered non-invasive electromagnetic neurorecovery device for stroke rehabilitation.

BrainQ Non-Invasive BCI by BrainQ · Catalog entry · 1 source · not yet field-verified · Biometric wearables


MedStar National Rehabilitation Hospital — first site to enroll patient in BrainQ pivotal EMAGINE trial Dec 9, 2021. Frequency-tuned electromagnetic field therapy for ischemic stroke. Up to 150 subjects across 19 sites.

Safety record

No incidents on record for BrainQ Non-Invasive BCI at Washington, DC, USA.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-12
Company
BrainQ
Status
operational
First seen
2021-12-09
ID
bd53a1a8-e9ff-4f4f-aa38-e101d416f599

Timeline

  1. Dec 2021
    First recorded
    BrainQ Non-Invasive BCI first documented operating at Washington, DC, USA.
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Operates worldwide

BrainQ Non-Invasive BCI is deployed globally rather than at a single verified site, so there is no map pin.

Free to use on your site, with a link back to DEPLOY.

BrainQ Non-Invasive BCI operates in Washington, DC, USA. Explore the full verified map:

Sources (1)

  1. https://www.prnewswire.com/il/news-releases/first-patient-enrolled-in-brainqs-pivotal-trial-emagine-301441414.html
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-12

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-12

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for BrainQ Non-Invasive BCI at Washington, DC, USA.

Common questions

What is the BrainQ Non-Invasive BCI deployment at Washington, DC, USA?
BrainQ Non-Invasive BCI, built by BrainQ, is recorded as a deployment at Washington, DC, USA on the DEPLOY registry. BrainQ operates the deployment directly.
Who operates BrainQ Non-Invasive BCI at Washington, DC, USA?
BrainQ, the manufacturer of BrainQ Non-Invasive BCI, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the BrainQ Non-Invasive BCI deployment at Washington, DC, USA go live?
The deployment is recorded as starting December 9, 2021 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the BrainQ Non-Invasive BCI deployment at Washington, DC, USA?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces